Celldex Therapeutics
CLDX
CLDX
130 hedge funds and large institutions have $183M invested in Celldex Therapeutics in 2017 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 42 increasing their positions, 41 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
28% less call options, than puts
Call options by funds: $577K | Put options by funds: $798K
38% less capital invested
Capital invested by funds: $295M → $183M (-$113M)
Holders
130
Holding in Top 10
2
Calls
$577K
Puts
$798K
Top Buyers
| 1 | +$6.19M | |
| 2 | +$4.09M | |
| 3 | +$3.06M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$2.02M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.75M |
Top Sellers
| 1 | -$13.1M | |
| 2 | -$10.7M | |
| 3 | -$6.42M | |
| 4 |
TCMG
TSP Capital Management Group
Summit,
New Jersey
|
-$3.84M |
| 5 |
Renaissance Technologies
New York
|
-$3.36M |